Sandy Liebhard

Sandy A. Liebhard, a founding partner at Bernstein Liebhard LLP, has successfully represented plaintiffs in complex litigations for more than 20 years. As dedicated consumer advocates, Mr. Liebhard and his fellow attorneys have taken on some of the largest corporate interest in the nation in cases involving dangerous pharmaceuticals, faulty medical devices and defective consumer products. As an author for RXInuryHelp.com, Mr. Liebhard has written extensively on the litigation involving proton pump inhibitors (Nexium, Prilosec, PrevAcid, etc.) and kidney injuries; Risperdal and gynecomastia; the Bair Hugger forced air warming blanket; talcum powder and ovarian cancer; transvaginal mesh; power morcellators; defective hip implants; and more.

Mr. Liebhard is a 1988 graduate of Brooklyn Law School. He is admitted to the Bar of the State of New York, as well as the United States District Courts for the Southern and Eastern Districts of New York.


Johnson & Johnson Settles Thousands of Metal-on-Metal Hip Lawsuits

Johnson & Johnson and its DePuy Orthopaedics subsidiary have settled thousands of metal-on-metal hip lawsuits involving the Pinnacle Hip Replacement System. DePuy Pinnacle Hip Lawsuits The metal-on-metal version of DePuy’s Pinnacle hip system – which utilizes the Ultamet liner — … Continue reading

Abilify Gambling Lawsuits Heading to Trial Next Summer

The federal court overseeing thousands of Abilify gambling lawsuits has chosen six cases for trials that will be convened during the summer of 2019. According to an Order issued in the U.S. District Court, Northern District of Florida, on December … Continue reading

Proton Pump Inhibitor Side Effects Highlighted in Two New Studies

Heart burn drugs like Nexium, Prilosec, and PrevAcid, have been linked to serious proton pump inhibitor side effects, including kidney failure and other renal complications. Now two new studies are highlighting potential risks to children and patients prone to hip … Continue reading

Chinese Company Behind Contaminated Valsartan Hit with FDA Warning Letter

The U.S. Food & Drug Administration (FDA) has issued a Warning Letter to the Chinese manufacturer behind a global recall of contaminated valsartan tablets. Cancer-Causing Chemical Detected in Valsartan API Valsartan is the generic name for Diovan, a prescription medication … Continue reading

Monsanto Roundup Lawsuit News: Federal Judge to Screen Jurors for Bias Ahead of First Cancer Trial

The judge overseeing the first federal trial of a Monsanto Roundup lawsuit has agreed to screen jurors with knowledge of a landmark verdict awarded earlier this year in a similar state court case. According to Law.com, attorneys for Bayer sought … Continue reading

IVC Filter Linked to Higher Death Rates in Older Adults with Pulmonary Embolism

A new study suggests older patients with pulmonary embolism are more likely to die if they receive an inferior vena cava (IVC) filter. FDA Warning on IVC Filter Complications IVC filters treat patients at risk for pulmonary embolism when standard … Continue reading

MRI Contrast Dye Lawsuits: Study Suggests AI Could Reduce Gadolinium Retention Risk

As patients in the United States continue to file MRI contrast dye lawsuits, a new study suggests artificial intelligence could be used to reduce risks potentially associated with gadolinium retention. Gadolinium MRI Contrast Dyes Gadolinium is a toxic heavy metal … Continue reading

Medtronic Denied Bid to Dismiss Fraud Claims in Spinal-Cord Stimulator Injury Case

A federal judge in Michigan has denied Medtronic’s Inc.’s motion to dismiss fraud claims asserted in a  lawsuit involving its PrimeAdvanced spinal-cord stimulator implant. Spinal-Cord Stimulator Injury Allegations According to a complaint filed in the U.S. District Court, Eastern District … Continue reading

Viberzi Lawsuit Claims Allergan’s Pancreatitis Warning Came Too Late

A new Viberzi lawsuit filed in Pennsylvania claims Allergan USA withheld important safety information from patients and doctors in the United States. Specifically, the fact that Viberzi increases the risk for pancreatitis in patients without a gallbladder Viberzi Lawsuit Allegations … Continue reading

Mounting HIV Drug Lawsuit Filings Allege Gilead Withheld Safer TDF Alternative

Yet another HIV drug lawsuit claims Gilead maximized profits by deliberately delaying the development  tenofovir alafenamide (TAF), despite a better safety profile compared to tenofovir disoproxil fumarate (TDF). Gilead Monopolizes HIV anti-viral Drug Market The U.S. Food & Drug Administration … Continue reading

Follow Us

RXInjuryHelp.com on Google+  RXInjuryHelp.com on Facebook  RXInjuryHelp.com on LinkedIn  RXInjuryHelp.com on Twitter  RXInjuryHelp.com on YouTube  RXInjuryHelp.com on Pinterest

Skip to content